Amgen (AMGN) is making waves after its VESALIUS-CV Phase 3 trial demonstrated that Repatha significantly lowers major cardiovascular events in at-risk patients who have not had a prior heart attack or ...

Amgen Inc. (NASDAQ:AMGN) is one of the Best Wide Moat Stocks to Buy Right Now. The company possesses a wide economic moat, which is backed by its intellectual property and brand reputation. On October ...

Cardiologists often struggle to assess heart attack risk. New startups using AI could help. For all the modern marvels of cardiology, we struggle to predict who will have a heart attack. Many people ...

Amgen Inc. (NASDAQ:AMGN) is one of the best growth stocks to buy now. On October 2, Amgen announced that its landmark Phase 3 VESALIUS-CV clinical trial met its dual primary endpoints, confirming that ...

What if your browser didn’t just help you search, but actively worked alongside you, summarizing articles, drafting emails, or even automating repetitive tasks? Enter ChatGPT Atlas, OpenAI’s ambitious ...

"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...

Leqvio may cause injection site reactions, including bruising, pain, discoloration, itchiness, and a burning or prickling sensation at the injection site. In addition to injection site reactions, ...

Pfizer's acquisition of biotechnology firm Metsera is expected to speed up its re-entry into the lucrative market for obesity treatments, currently dominated by Eli Lilly and Danish rival Novo Nordisk ...

Amgen cholesterol drug cuts risk of first cardiac event by 25% Adding Amgen's cholesterol drug Repatha to standard therapy reduced major cardiovascular events by 25% for at-risk patients who have ...

Pectin, a type of fiber in the cell walls of plants, helps give plants their structure (1). Apple pectin is extracted from apples, which are some of the richest sources of fiber. Roughly 15–20% of the ...